217 related articles for article (PubMed ID: 22983529)
21. CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
Wei J; Yu G; Shao G; Sun A; Chen M; Yang W; Lin Q
Oncotarget; 2016 May; 7(21):31067-78. PubMed ID: 27105510
[TBL] [Abstract][Full Text] [Related]
22. Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China.
Guo W; Dong Z; Bai Y; Guo Y; Shen S; Kuang G; Xu J
Tumour Biol; 2015 Apr; 36(4):2845-54. PubMed ID: 25476857
[TBL] [Abstract][Full Text] [Related]
23. Promoter methylation of Raf kinase inhibitory protein: A significant prognostic indicator for patients with gastric adenocarcinoma.
Li DX; Cai HY; Wang X; Feng YL; Cai SW
Exp Ther Med; 2014 Sep; 8(3):844-850. PubMed ID: 25120612
[TBL] [Abstract][Full Text] [Related]
24. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
Minoo P; Zlobec I; Baker K; Tornillo L; Terracciano L; Jass JR; Lugli A
Am J Clin Pathol; 2007 May; 127(5):820-7. PubMed ID: 17439843
[TBL] [Abstract][Full Text] [Related]
25. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
[TBL] [Abstract][Full Text] [Related]
26. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
Qu WZ; Wang L; Chen JJ; Wang Y
World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of C/EBP homologous protein (CHOP) expression in gastric cardia adenocarcinoma: Their relationship with clinicopathological parameters and prognostic significance.
Zhu XJ; Gao SG; Li SQ; Shi ZG; Ma ZK; Zhu SS; Feng XS
Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):391-8. PubMed ID: 25582300
[TBL] [Abstract][Full Text] [Related]
28. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma.
Liu W; Dong Z; Liang J; Guo X; Guo Y; Shen S; Kuang G; Guo W
Cancer Invest; 2016 Nov; 34(10):506-516. PubMed ID: 27791400
[TBL] [Abstract][Full Text] [Related]
30. Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.
Sun A; Yu G; Dou X; Yan X; Yang W; Lin Q
Mol Cancer; 2014 Nov; 13():248. PubMed ID: 25395181
[TBL] [Abstract][Full Text] [Related]
31. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression and aberrant methylation of Raf kinase inhibitory protein gene in esophageal squamous cell carcinoma.
Guo W; Dong Z; Lin X; Zhang M; Kuang G; Zhu T
Cancer Invest; 2012 Dec; 30(10):703-11. PubMed ID: 23066640
[TBL] [Abstract][Full Text] [Related]
33. Different expression pattern and significance of p14ARF-Mdm2-p53 pathway and Bmi-1 exist between gastric cardia and distal gastric adenocarcinoma.
Yao D; Wang Y; Xue L; Wang H; Zhang J; Zhang X
Hum Pathol; 2013 May; 44(5):844-51. PubMed ID: 23159155
[TBL] [Abstract][Full Text] [Related]
34. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
Chatterjee D; Sabo E; Tavares R; Resnick MB
Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study.
Amini N; Spolverato G; Kim Y; Squires MH; Poultsides GA; Fields R; Schmidt C; Weber SM; Votanopoulos K; Maithel SK; Pawlik TM
J Surg Oncol; 2015 Mar; 111(3):285-92. PubMed ID: 25308915
[TBL] [Abstract][Full Text] [Related]
36. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
37. RKIP expression associated with gastric cancer cell invasion and metastasis.
Jia B; Liu H; Kong Q; Li B
Tumour Biol; 2012 Aug; 33(4):919-25. PubMed ID: 22246605
[TBL] [Abstract][Full Text] [Related]
38. Reduced RKIP Expression is Associated With Breast Neoplastic Progression and is Correlated With Poor Outcomes and Aberrant Methylation in Breast Carcinoma.
Kim GE; Kim NI; Lee JS; Park MH; Yoon JH
Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):467-474. PubMed ID: 26894644
[TBL] [Abstract][Full Text] [Related]
39. Loss of RKIP expression is associated with poor survival in GISTs.
Martinho O; Gouveia A; Silva P; Pimenta A; Reis RM; Lopes JM
Virchows Arch; 2009 Sep; 455(3):277-84. PubMed ID: 19705153
[TBL] [Abstract][Full Text] [Related]
40. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
Fu Z; Kitagawa Y; Shen R; Shah R; Mehra R; Rhodes D; Keller PJ; Mizokami A; Dunn R; Chinnaiyan AM; Yao Z; Keller ET
Prostate; 2006 Feb; 66(3):248-56. PubMed ID: 16175585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
